France-based D&A Pharma has entered into an exclusive supply, licensing and distribution agreement with Grupo Juste for Alcover, sodium oxybate, a treatment for alcohol dependence.

As part of the deal, Grupo Juste will distribute Alcover in Spain and Central American countries such as Nicaragua, Panama, Costa Rica, Salvador, Honduras, Guatemala, Belize and the Dominican Republic.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
"We are extremely satisfied to announce the arrival of this unique drug as a result of the incredible job that the D&A Pharma team has carried out over the past seven years."

Grupo Juste president Inés Juste said: "We are extremely satisfied to announce the arrival of this unique drug as a result of the incredible job that the D&A Pharma team has carried out over the past seven years."

D&A is also eligible to receive milestone payments and royalties on future sales of Alcover in the designated territory, in addition to the initial upfront payment.

Currently, Alcover is distributed in Italy and Austria.

See Also:

D&A Pharma president Patrice Debregeas said: "We are very pleased to announce this agreement with Grupo Juste, a pharma company uniquely positioned in Hispanic countries.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

"Grupo Juste can draw on its considerable experience to build a powerful franchise in the addiction area and will leverage Alcover’s penetration thanks to its strong local presence and regulatory expertise in Spain and Central America."

According to the European Medicines Agency’s current evaluation criteria, all the clinical trials carried out in Europe have evaluated the efficacy and safety of sodium oxybate.